Erratum: Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53 (Nature (2014) 511 (478-482) doi:10.1038/nature13298);Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53

Nature

Volumn 511, Issue 7510, 2014, Pages 478-482

  Viros, Amaya ^a   Sanchez Laorden, Berta ^a   Pedersen, Malin ^b   Furney, Simon J ^a   Rae, Joel ^b   Hogan, Kate ^a   Ejiama, Sarah ^a   Girotti, Maria Romina ^a   Cook, Martin ^a,c   Dhomen, Nathalie ^b   Marais, Richard ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MILK SUNSCREEN; PROTEIN P53; SUNSCREEN; SUNSENSE MILK SUNSCREEN; UNCLASSIFIED DRUG;

CANCER; DATA SET; EPIDEMIOLOGY; GENE EXPRESSION; MOLECULAR ANALYSIS; MUTATION; NUMERICAL MODEL; RODENT; TUMOR; ULTRAVIOLET RADIATION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CARCINOGENESIS; CODON; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA DAMAGE; FEMALE; MELANOCYTE; MELANOMA; MELANOMAGENESIS; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUNBURN; ULTRAVIOLET RADIATION; WILD TYPE;

MUS;

ANIMALS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DNA DAMAGE; FEMALE; HUMANS; MELANOCYTES; MELANOMA; MICE; MICE, INBRED C57BL; MUTAGENESIS; MUTATION; NEVUS; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; SUNBURN; SUNSCREENING AGENTS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 84904855599     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14057     Document Type: Erratum

References (38)

1. Whiteman, D. C. et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J. Natl. Cancer Inst. 95, 806-812 (2003).
2. Gilchrest, B. A., Eller, M. S., Geller, A. C. & Yaar, M. The pathogenesis of melanoma induced by ultraviolet radiation. N. Engl. J. Med. 340, 1341-1348 (1999).
3. Yeh, I., von Deimling, A. & Bastian, B. C. Clonal BRAFmutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. J. Natl. Cancer Inst. 105, 917-919 (2013).
4. Tsao, H., Chin, L., Garraway, L. A. & Fisher, D. E. Melanoma: From mutations to medicine. Genes Dev. 26, 1131-1155 (2012).
5. Harrison, S. L., MacLennan, R., Speare, R. & Wronski, I. Sun exposure and melanocytic naevi in young Australian children. Lancet 344, 1529-1532 (1994).
6. Dhomen, N. et al. Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell 15, 294-303 (2009).
7. Pontén, F., Berne, B., Ren, Z. P., Nister, M. & Ponten, J. Ultraviolet light induces expression of p53 and p21 in human skin: Effect of sunscreen and constitutive p21 expression in skin appendages. J. Invest. Dermatol. 105, 402-406 (1995).
8. Rudolph, P., Tronnier, M., Menzel, R., Moller, M. & Parwaresch, R. Enhanced expression of Ki-67, topoisomerase IIa, PCNA, p53 and p21WAF1/Cip1 reflecting proliferation and repair activity in UV-irradiatedmelanocytic nevi.Hum. Pathol. 29, 1480-1487 (1998).
9. Pollock, P. M. et al. High frequency of BRAF mutations in nevi. Nature Genet. 33, 19-20 (2002).
10. Thomas, N. E. et al. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol. Biomarkers Prev. 16, 991-997 (2007).
11. Vultur, A. & Herlyn, M. SnapShot: melanoma. Cancer Cell 23, 706 (2013).
12. Pfeifer, G. P., You, Y. H. & Besaratinia, A. Mutations induced by ultraviolet light. Mutat. Res. 571, 19-31 (2005).
13. Kato, S. et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl Acad. Sci. USA 100, 8424-8429 (2003).
14. Song, H.,Hollstein, M.&Xu, Y. p53 gain-of-function cancermutants induce genetic instability by inactivating ATM. Nature Cell Biol. 9, 573-580 (2007).
15. Willis, A., Jung, E. J.,Wakefield, T.& Chen, X.Mutantp53 exerts a dominantnegative effect by preventingwild-typep53frombinding to the promoter of its target genes. Oncogene 23, 2330-2338 (2004).
16. Olive, K. P. et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847-860 (2004).
17. Dankort, D. et al. BrafV600E cooperates with Pten loss to induce metastatic melanoma. Nature Genet. 41, 544-552 (2009).
18. Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251-263 (2012).
19. Krauthammer, M. et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nature Genet. 44, 1006-1014 (2012).
20. Patton, E. E. & Zon, L. I. Taking human cancer genes to the fish: A transgenicmodel of melanoma in zebrafish. Zebrafish 1, 363-368 (2005).
21. Goel, V. K. et al. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice. Oncogene 28, 2289-2298 (2009).
22. Bald, T. et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 507, 109-113 (2014).
23. Noonan, F. P. et al. Neonatal sunburn and melanoma in mice. Nature 413, 271-272 (2001).
24. Luo, C. et al. Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC. Cancer Res. 73, 4337-4348 (2013).
25. Zaidi, M. R. et al. Interferon-c links ultraviolet radiation to melanomagenesis in mice. Nature 469, 548-553 (2011).
26. Green, A. et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial. Lancet 354, 723-729 (1999).
27. Green, A. C., Williams, G. M., Logan, V. & Strutton, G. M. Reduced melanoma after regular sunscreen use: Randomized trial follow-up. J. Clin. Oncol. 29, 257-263 (2011).
28. Goldenhersh, M. A. & Koslowsky, M. Increased melanoma after regular sunscreen use? J. Clin. Oncol. 29, e557-e558 (2011).
29. Planta, M. B. Sunscreen andmelanoma: Is our prevention message correct? J. Am. Board Fam. Med. 24, 735-739 (2011).
30. Viros, A. et al. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med. 5, e120 (2008).
31. Workman, P. et al. Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer 102, 1555-1577 (2010).
32. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
33. McKenna, A. et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
34. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
35. Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568-576 (2012).
36. Larson, D. E. et al. SomaticSniper: Identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28, 311-317 (2012).
37. McLaren, W. et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26, 2069-2070 (2010).
38. Turajlic, S. et al. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res. 22, 196-207 (2012).